
Advanced O
Medical O
buying O
IVAC B-MISC
Medical I-MISC
. O

SAN B-LOC
DIEGO I-LOC
1996-08-26 O

Advanced B-ORG
Medical I-ORG
Inc I-ORG
. O
said O
Monday O
it O
will O
buy O
IVAC B-MISC
Medical I-MISC
Systems O
Inc. O
, O
a O
former O
Eli B-ORG
Lilly I-ORG
& I-ORG
Co I-ORG
. O

unit O
, O
for O
about O
$ O
400 O
million O
in O
cash O
, O
creating O
one O
of O
the O
world O
's O
largest O
makers O
of O
intravenous O
infusion B-MISC
therapy I-MISC
products O
. O

Under O
the O
agreement O
, O
IVAC O
and O
Advanced O
Medical O
's O
wholly O
owned O
subsidiary O
, O
IMED O
Corp. O
, O
will O
merge O
to O
form O
a O
new O
company O
that O
will O
develop O
and O
manufacture O
infusion B-MISC
pumps I-MISC
that O
regulate O
the O
amount O
of O
intravenous B-MISC
fluid I-MISC
being O
administered O
to O
a O
patient B-MISC
, O
as O
well O
as O
proprietary B-MISC
disposable I-MISC
products I-MISC
. O

The O
combined O
company O
will O
have O
estimated O
revenues O
of O
$ O
353 O
million O
. O

Advanced O
Medical O
, O
through O
IMED O
, O
is O
already O
one O
of O
the O
nation O
's O
largest O
developers O
and O
manufacturers O
of O
intravenous O
infusion B-MISC
pumps I-MISC
and O
proprietary B-MISC
disposable I-MISC
products I-MISC
. O

It O
has O
sales O
in O
38 O
foreign O
countries B-MISC
. O

San B-LOC
Diego I-LOC
-based O
IVAC O
is O
a O
major O
provider O
of O
infusion O
systems O
and O
related O
technologies O
to O
the O
health-care O
industry O
. O

It O
has O
manufacturing O
plants O
in O
San B-LOC
Diego I-LOC
; O
Creedmoor B-LOC
, O
N.C. B-LOC
; O
Hampshire B-LOC
, O
England B-LOC
; O
and O
Tijuana B-LOC
, O
Mexico B-LOC
, O
and O
distributes O
its O
prodcuts O
in O
more O
than O
120 O
countries B-MISC
. O

Eli O
Lilly O
sold O
IVAC O
on O
Dec. O
31 O
, O
1994 O
to O
DLJ B-ORG
Merchant I-ORG
Banking I-ORG
Partners I-ORG
LP I-ORG
, O
River B-ORG
Medical I-ORG
Inc. I-ORG
and O
other O
investors O
. O

Advanced O
Medical O
said O
it O
expects O
to O
take O
an O
unspecified O
one-time O
charge O
to O
pay O
for O
the O
merger B-MISC
. O

It O
did O
not O
say O
when O
the O
charge O
would O
be O
taken O
. O

The O
addition O
of O
IVAC O
is O
expected O
to O
contribute O
to O
financial O
results O
in O
the O
full O
second O
quarter O
of O
1997 O
, O
the O
companies O
said O
. O

The O
merger B-MISC
will O
add O
to O
both O
companies O
' O
historical O
leadership O
in O
infusion B-MISC
therapy I-MISC
and O
technology-based O
drug O
delivery O
devices O
, O
they O
said O
. O

In O
1968 O
, O
IVAC O
introduced O
the O
world O
's O
first O
infusion B-MISC
therapy I-MISC
monitoring O
device O
. O

A O
year O
later O
IVAC O
improved O
its O
system O
with O
the O
addition O
of O
an O
IV O
pump O
that O
regulated O
the O
flow O
of O
liquids O
through O
positive O
pressure O
. O

IMED O
introduced O
the O
world O
's O
first O
volumetric B-MISC
infusion I-MISC
pump I-MISC
in O
1974 O
. O

IMED O
had O
profits O
of O
$ O
1.7 O
million O
, O
or O
6 O
cents O
per O
fully O
diluted B-MISC
common I-MISC
share I-MISC
, O
on O
$ O
53.9 O
million O
in O
revenues O
in O
the O
first O
half O
of O
1996 O
. O

Excluding O
the O
effect O
of O
a O
one-time O
restructuring O
charge O
of O
$ O
17.4 O
million O
, O
IVAC O
had O
net O
income O
of O
$ O
4.2 O
million O
on O
net O
sales O
of O
$ O
112.8 O
million O
for O
the O
1996 O
first O
half O
. O

Advanced O
Medical O
reported O
profits O
of O
$ O
8.4 O
million O
on O
sales O
of O
$ O
29.2 O
million O
in O
the O
quarter O
ended O
June O
30 O
. O

William B-PER
J. I-PER
Mercer I-PER
, O
IVAC O
president O
and O
chief B-MISC
executive I-MISC
officer I-MISC
, O
will O
become O
the O
president O
and O
CEO O
of O
Advanced O
Medical O
. O

He O
led O
the O
transition O
of O
IVAC O
to O
a O
privately O
held O
company O
and O
was O
previously O
senior O
vice O
president O
at O
Mallinckrodt B-ORG
Group I-ORG
Inc I-ORG
. O

Joseph B-PER
Kuhn I-PER
, O
Advanced O
Medical O
and O
IMED O
president O
, O
will O
become O
the O
new O
company O
's O
executive B-MISC
vice I-MISC
president I-MISC
and O
chief B-MISC
financial I-MISC
officer I-MISC
. O

The O
deal O
is O
expected O
to O
close O
by O
the O
first O
quarter O
of O
1997 O
, O
subject O
to O
regulatory O
approval O
. O

It O
has O
already O
been O
approved O
by O
both O
companies O
' O
boards O
. O

